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ABSTRACT: This study was designed to find out the impact of diabetes mellitus on the renal integrity of 
diabetic patients following exposure to hypertension and diabetes. This was achieved by examining the urea and 
creatinine concentrations and creatinine clearance of both diabetics and non-diabetics in Port Harcourt. A total 
of 165 subjects comprising 32 (19.39%) male diabetics, 53 (31.12%) female diabetics, 48 (29.09%) non-
diabetic males and 32 (19.39%) non-diabetic females participated in the study. Results showed that 9.09% of 
male and 21.91% of female diabetics were hypertensive. Mean urea concentrations obtained were 6.35 ±1.55 
mmol/L and 5.56 ± 2.24 mmol/L in the diabetic males and females respectively while in the non-diabetic males 
and females, the results were 5.66 ± 1.23 mmol/L and 5.07 ± 1.71 mmol/L respectively which was not 
significantly different (p>0.05, F crit. = 1.98). The creatinine concentration in the diabetic males and females 
were 93.46 ± 24.97 µmol/L and 89.15 ± 28.01 µmol/L respectively while in the non-diabetic male and female 
subjects it was 84.64 ± 29.06 µmol/L and 81.69 ± 37.27 µmol/L respectively. These means were not significant 
(p>0.05, F crit. = 1.65). In both male and female diabetics, the creatinine clearance was reduced in the subjects 
following 8 years and above of exposure to diabetes mellitus, which is an indication of commencement of 
progressive loss of renal function in the diabetic patients. Thus, measurement of creatinine clearance should be 
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Diabetes mellitus is a chronic disease that is 
spreading worldwide (International Diabetes 
Federation, 2010). According to the World Health 
Organization (WHO) at least 171 million people 
worldwide are at risk of diabetes mellitus (Wild et al. 
2004). Its incidence is increasing rapidly, and it is 
estimated that by the year 2030, this number would 
double (International Diabetes Federation, 2006). 
Diabetes mellitus occurs throughout the world, but it 
is more common in the developed countries (The 
Improved Diabetes Atlas, 2006). The increase in the 
incidence of diabetes in developing countries follows 
the trend of urbanization and lifestyle changes but 
there is little understanding of the mechanisms 
(Rother, 2007). In a follow-up cross-sectional study 
of people living with diabetes in Rivers state (a core 
Niger Delta region), it was revealed that diabetes 
contributes substantially to the health problem; with 
type 2 diabetics presenting at diagnosis with the 
following complications, viz: neuropathy 439 
(56.3%), erectile dysfunction 283 (36.3%), 
nephropathy 72 (9.2%) and retinopathy 57(7.3%) 
(Chinenye and Young, 2011) 
 
In a survey conducted in Port Harcourt metropolis, 
the prevalence of hypertension was found to be 
40.82% out of which 13.03% were unaware of being 
hypertensive and 27.79% were already receiving 
treatment for hypertension Among those found to be 
hypertensive, 17.55% had family history of 
hypertension, and 12.23% had family history of 
diabetes mellitus (Akpa et al., 2008). However, in a 
review study of hypertension in Nigeria, the 
prevalence of hypertension in both men and women 
ranged from 8% to 46.4%; with regards to gender, the 
prevalence of hypertension ranged from 7.9% to 
50.2% and 3.5% to 6.8.8% in men and women, 
respectively. The reported prevalence in rural areas 
ranged from 13.5%-46.4% in both sexes, 14.7%-
49.5% in men and 14.3-68.8% in women. Data from 
urban studies revealed a range of 8.1%-42.0% in both 
men and women, 7.9%-46.3% for men and 3.5%-
37.7% for women. In general hypertension 
prevalence was higher in urban than rural areas 
(Ogah et al., 2012). 
 
Diabetes mellitus and hypertension has been found to 
co-exist in a number of patients. About 10 to 15% 
and 1 to 2% of Nigerians have hypertension and 
diabetes respectively (Akinkugbe, 2000). Data 
obtained from death certificates in the U.S.A. 
indicates that hypertension has been implicated in 
44% of deaths coded to diabetes, and diabetes is 
involved in 10% of deaths to hypertension (Horan, 
1984). The coexistence of these two diseases likely 
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contributes substantially to overall mortality in 
industrialized societies (Epstein and Sowers, 1992). 
 
Elevated serum creatinine level (80 µmol/L and 97 
µmol/L) for elderly women and men respectively has 
been established with increased mortality in 
hypertensive persons with complications of type 2 
diabetes mellitus and cardiovascular disease (Lynch 
and Wu, 2010). The literature relating levels of renal 
indices such as creatinine, urea, creatinine clearance 
in hypertensive and normotensive subjects and 
diabetes type 2 subjects is scarce in Nigeria. 
Realizing that diabetes mellitus and renal failure are 
major public health concerns, this study was designed 
to investigate the levels of these indices of renal 
function and blood pressure measurements in type 2 
diabetic mellitus subjects in Port Harcourt, Nigeria. 
 
MATERIALS AND METHODS 
Subject selection: The study was carried out on 
subjects attending the out-patients’ department of the 
Braithwaite Memorial Hospital, Port Harcourt, 
South- South Nigeria. The sample size was 
determined using the Taro Yamane’s formula 
(Yamane, 1967) based on a prevalent hypertension 
population size of 45.4% as reported by Nwafor and 
Owhorji, (2001) in Port Harcourt. A total of one 
hundred and sixty- five (165) subjects participated in 
the study out of which sixty- four (64) were males 
and one hundred and one (101) were females. The 
subjects who participated in the study were within the 
age of 31 and 85 years. 
 
Ethical Issues: Ethical approval and clearance was 
received from the Ethics Committee of the Rivers 
State Health Management Board and the Local Ethics 
Committee of the Braithwaite Memorial Hospital, 
Port Harcourt, Nigeria. The subjects voluntarily gave 
oral consent to participate in the study after the 
objectives of the study was explained to them. 
 
Data collection:  Information on history of 
hypertension and diabetes mellitus was obtained 
using a set of structured questionnaire. Diabetes 
mellitus was defined by participants' medical history 
and the diagnosis was based on the World Health 
Organization (WHO) criteria (Expert Committee on 
the Diagnosis and Classification of diabetes mellitus, 
1997). Systolic blood pressure > 140mmHg and/or 
diastolic blood pressure > 90mmHg measured using 
standard procedures were used to make a diagnosis of 
hypertension (Guideline subcommittee, 1999). Blood 
pressure was obtained 3 times from each subject 
during the survey. Each measurement was made 
using a mercury sphygmomanometer, with the 
participant seated. The arithmetic mean was then 
calculated using all available systolic and diastolic 
readings. In this analysis, individuals with a systolic 
blood pressure lower than 140 mm Hg and diastolic 
blood pressure lower than 90 mm Hg who were not 
receiving antihypertensive treatment were defined as 
normotensive. Individuals were classified as 
hypertensive if they had a mean blood pressure of 
140 mmHg or higher (systolic) or 90 mmHg or 
higher (diastolic) or reported current use of 
medication for hypertension (Burt et al., 1995). The 
height was measured (in metres) to the nearest 0.1 m 
with a calibrated meter rule placed horizontally 
against the wall while the weight of the subjects was 
measured (in kilograms) with participants wearing 
light clothing and no shoes, and recorded to the 
nearest 0.1 kg as recommended by the World Health 
Organization (WHO, 1995). 
 
Determination of Serum Creatinine: Serum creatinine 
level was determined by the alkaline Jaffe’s Picrate 
(Owen et al.,1954). The Jaffe’s method for serum 
creatinine determination is based on the principle that 
picric acid in an alkaline medium reacts with 
creatinine to form an orange coloured complex with 
the alkaline picrate. The absorbance of the complex 
formed whose intensity is directly proportional to the 
amount of creatinine present in the sample is read in 
a spectrophotomer at 490nm. 
 
Determination of Serum urea: The serum urea level 
was determined by the diacetyl monoxime method as 
reported by Cheesbrough, (2005). In the diacetyl 
monoxime method, urea reacts with diacetyl 
monoxime at high temperature in an acid medium in 
the presence of cadmium ions and thiosemicarbazide 
to produce a red coloured solution whose absorbance 
is read at 530nm in spectrophotomer. 
 
Determination of Plasma Glycated Haemoglobin 
A1c: Diabetes mellitus in the subjects was confirmed 
by the determination of plasma glycated haemoglobin 
A1c by the method of Bisse and Abraham (1985). 
The method involves chromatographic-
spectrophotometric ion exchange procedures for the 
determination of haemoglobin A1c. The 
glycohaemoglobin procedure employs a weakly 
binding cation-exchange resin for rapid separation of 
glycohaemoglobin (fast fraction) from non-
glycosylated haemoglobin. The percent 
glycohaemoglobin is determined by measuring 
absorbance at 415nm for the glycohaemoglobin 
fraction and the total haemoglobin fraction, 
calculating the ratio of the absorbance. An HbA1c of 
6.5% as recommended by WHO (2011) was adopted 
as the cut point for diagnosing diabetes and subjects 
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with HbA1c values below 6.5% were regarded as 
non- diabetic. 
 
Determination of Creatinine Clearance (Calculated): 
The creatinine clearance which is practically the 
same as the glomerular filtration rate was estimated 
using Cockcroft-Gault formula (Cocroft and Gault, 
1976). The formula takes into account various factors 
that affects the estimation of muscle mass and 
assumed creatinine production since serum creatinine 
is so highly dependent on age, sex and body size.  It 
is given as: 
 
 Creatinine clearance (µmol/L) = (((140 - age) x 
weight)/ (0.814 x serum [creatinine]) x (0.85 if 
patient is female)), where creatinine clearance is in 
millilitres per minute, age is in years, weight is 
kilograms, [creatinine] in micromoles per litre. 
 
 
Statistical analysis: GraphPad Instat Version 3.10, 12 
bit for windows was used for the statistical evaluation 
of the results obtained. All data are presented as 
means ± SD since variables presented were normally 
distributed. One-way analysis of variance (ANOVA) 
was also used as appropriate to compare means of 
variables. Variation in means was considered 
significant at p<0.05. 
 
 RESULTS AND DISCUSSION 
There were one hundred and sixty-five subjects 
comprising 32 subjects (19.39%) who were male 
diabetics, 53 subjects (32.12%) who were female 
diabetics, 48 subjects (29.09%) who were non-
diabetic males, and 32 subjects (19.39%) who were 
non-diabetic females.  Amongst the diabetics, 15 
male subjects (9.09%) and 36 female subjects 
(21.81%) were hypertensive whilst 15 male subjects 
(9.09%) and 18 female subjects (10.91%) were 
normotensive. The mean ± SD of the systolic blood 
pressure (SBP) obtained from the diabetic male and 
female subjects were 142.55 ± 10.48 mmHg and 
149.88 ± 21.67 mmHg while the diastolic blood 
pressure (DBP) were 90.77 ± 11.75 mmHg and 90.70 
± mmHg respectively. Also, the mean ± SD of the 
systolic blood (SBP) pressure obtained from the non-
diabetic male and female subjects were 129.82 ± 6.87 
mmHg and 82.85 ± 7.06 mmHg while the diastolic 
blood pressure (DBP) were 79.59 ± 11.75 mmHg and 
90.70 ± mmHg respectively. Comparison of the 
means of the systolic blood pressure between the 
diabetic male, diabetic female, non-diabetic male and 
non-diabetic female subjects using analysis of 
variance (ANOVA) showed significant difference 
(p<0.05, F-crit. =24.83). Similarly, the comparison of 
the means of the diastolic blood pressure between the 
diabetic male, diabetic female, non-diabetic male and 
non-diabetic female subjects using analysis of 
variance (ANOVA) also showed significant 
difference (p<0.05, F-crit.=18.83).  
 
Furthermore, the mean ± SD of the serum urea 
concentration of the diabetic male and female 
subjects were 6.36 ± 1.55 mmol/L (4.81-
7.91mmol/L) and 5.56 ± 2.24 mmol/L (3.32-7.80 
mmol/L) respectively. The mean ± SD of the serum 
urea concentration of the non-diabetic male and 
female subjects were 5.66 ± 1.23 mmol/L (4.43-6.89 
mmol/L) and 5.07 ± 1.71 mmol/L (3.36-6.78 
mmol/L) respectively. The mean of serum urea 
concentrations in the male and female diabetic and 
non-diabetic subjects were not significantly different 
(p>0.05, F-crit.=1.98) when compared using 
ANOVA. The urea reference range used to compare 
with data obtained in this study was 2.5-8.0 mmol/L 
according to Tietz et al. (1995).  
 
The mean ± SD of the serum creatinine concentration 
in the diabetic male and female subjects were 93.46 ± 
24.97 µmol/L (68.49-118.43 µmol/L) and 89.15 ± 
28.01 µmol/L (61.14-117.17 µmol/L) respectively 
while the serum creatinine concentration in the non-
diabetic male subjects was 84.64 ± 29.06 µmol/L 
(55.58-113.7 µmol/L) and the mean ± SD of serum 
creatinine concentration for the non-diabetic female 
subjects was 81.69 ± 37.27 µmol/L (44.42-118.96 
µmol/L). The comparison of the means of serum 
creatinine concentration from all the subjects did not 
show significant difference (p>0.05, F-crit.=1.65). 
The male creatinine reference range used to compare 
with the data obtained in this study was 70-120 
µmol/L while the female creatinine reference range 
was 50-90 µmol/L according to Tietz et al. (1995).  
 
The mean ± SD of the estimated creatinine clearance 
for the diabetic male and female subjects were 91.61 
± 45.44 ml/min/1.73 m
2
 (46.17-137 ml/min/1.73 m
2
) 





). The creatinine clearance values for 
the male and female diabetics showed lower values at 
the lower range of normal. The creatinine clearance 
value for the non-diabetic male and female subjects 










) respectively. A non-
significant difference (p>0.05, F-crit.=1.32) was 
observed between these means. This is shown in table 
1. The means of the creatinine clearance for the non-
diabetic male and female subjects were generally 
within the normal limits reported by Tietz et al. 
(1995). 
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The mean ± SD of the creatinine clearance classified 
according to the number of years of exposure to or 
duration of type 2 diabetes mellitus in the subjects 
was determined and results shown in the table 2. The 
table showed that the mean ± SD of the creatinine 
clearance in the diabetic male (14.12%) and female 
(30.59%) subjects whose duration of exposure to 











) respectively. In those subjects whose 
duration of exposure to diabetes was between 4-7 





) in the 





) in the female subjects 
respectively. The creatinine clearance for the male 
diabetics (8.24%) whose duration of exposure to 
diabetics was from 8 years and above was 57.24± 
12.82 ml/min/1.73 (44.42-70.06 ml/min/1.73m
2
) 
while the creatinine clearance for the female diabetics 
whose duration of exposure to diabetes was from 8 
years and above (22.35%) was 83.04 ±33.67 
ml/min/1.73m
2
 (49.37- 116.67 ml/min/1.73m
2
). The 
reference range of creatinine clearance is 95-140 
ml/min/1.73m
2 
for males and 85-125 ml/min/1.73m
2
 
for females according to Tietz et al. (1995). These 
results showed reduced creatinine clearance in the 
lower range of normal for both male and female 
diabetics. Comparison of the means of the creatinine 
clearance according to the duration of exposure to 
diabetes mellitus using ANOVA amongst the male 
diabetics showed significant difference (p<0.05, F-
crit.=16.56) in the males while in the females no 
significant difference (p>0.05, F-crit.=1.23) was 
observed. The range of the creatinine clearance value 
was low at the lower limits of normal when compared 
with the reference range in both the male and female 
diabetics.  
 
Table 1: Blood Pressure Measurements and Some Renal Indices in the Subjects 








Diabetic Males  32 (19.39) 142.55 ± 10.48 90.77 ± 
11.85 
6.36 ± 1.55  93.46 ± 24.97 91.61 ± 45.44 
Non-Diabetic Males  32 (19.39) 129.82 ± 8.23 79.59 ± 6.87 5.66 ± 1.23 84.64 ±29.06 99.06 ± 26.34 
Diabetic Females  53 (32.12) 149.88 ±21.67 90.70 ± 
11.75 
5.56 ± 2.24 89.15 ± 28.01  85.15 ± 33.50 
Non-Diabetic 
Females 
48 (29.09) 127.70 ± 9.22 82.85 ± 7.06 5.07 ± 1.71 81.69 ± 37.26 90.09 ± 35.28 
P-value  p< 0.05, F=24.83 p<0.05, 
F=18.32 
p> 0.05, F=1.98 p> 0.05, F=1.65 p >0.05,  
F=1.32 
  Note: *Number in parenthesis represents percentages 
 SBP = Systolic blood pressure 
 DBP= Diastolic blood pressure 
 
Table 2 Table 2: Effect Duration of Diabetes Mellitus on Creatinine Clearance of Subjects 
Duration of Diabetes 
(years) 
Number of Subjects 
 (%)* Males 
Creatinine Clearance 
(ml/min/1.73m2 





0-3 12 (14.12) 72.67 ± 40.54 26 (30.59) 82.70 ± 34.12 
4-7 13 (15.29) 96.63 ± 24.75 8 (9.41) 81.81 ± 39.63 
8 and above 7 (8.24) 57.24 ± 12.82 19 (22.35) 83.04 ± 33.67 
p- value  p<0.05, F-crit.=16.56  p>0.05, F=1.23 
Note: *Number in parenthesis represents percentages 
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Diabetes mellitus (DM) is a chronic disorder that is not 
only assuming pandemic proportions worldwide but 
also poised to affect the developing countries of the 
world much more than their developed counterparts. 
Health care delivery as in most developing countries of 
the world is at best sub-optimal and this may be 
responsible for the dismal health indicator statistics 
such as reduced life expectancy at birth and increased 
maternal mortality.  In this study, hypertension was 
defined as systolic blood pressure (SBP) ≥ 140 and/ or 
diastolic blood pressure ≥ 90mmHg. In a study on the 
prevalence of hypertension amongst persons with 
diabetes mellitus in Benin City, Nigeria, the proportion 
of male diabetics with hypertension was shown to be 
50.8% and while that of the females was 49.2%. The 
prevalence of hypertension in type 2 diabetes mellitus 
subjects was also observed to be 58.9% combined for 
both males and females (Unadike et al., 2011). The 
incidence of hypertension has been reported to be 
almost twice in diabetics as in non-diabetics (Epstein 
and Showers, 1992; Williams and Pickup, 1999). 
Analysis from our data showed that 51.51% (19.39% 
and 32.12% of the diabetic male and female patients) 
were hypertensive which did not support earlier 
findings (Epstein and Showers, 1992; Williams and 
Pickup, 1999). Variable rates of hypertension in type 2 
diabetes mellitus subjects have also been reported, viz, 
30% (Okesina et al., 1995), 37% (Kumwenda et 
al.,1992) and 45% (Swai et al., 1990) respectively. Our 
finding indicates a rising trend in the prevalence of 
hypertension in patients with type 2 diabetes mellitus 
which may be attributable to changes in life style due to 
modernization and rural urban migration which is 
sweeping across Nigeria. The high prevalence rate of 
hypertension in type 2 diabetes mellitus patients in this 
study may also be due to much stress as a result of the 
harsh economic conditions prevalent in this region of 
Nigeria coupled with the high level of insecurity and 
fear arising from rampant kidnappings and militancy 
operations. 
 
In diabetic individuals, hypertension has been 
implicated in the accelerated progression of both 
microvascular and macrovascular complications 
(Williams, 1994). Diabetic nephropathy has also been 
reported to occur in approximately 1/3
rd
 of individuals 
with type 1 and type 2 diabetes mellitus. (Rehman et al., 
2005). Diabetic nephropathy which could lead to 
reduction in creatinine clearance, which is a function of 
glomerular filtration rate, was evidently observed in this 
study. Our study shows that 30.59% (8.24% males and 
22.35% females) with an average age of duration of 
diabetes of 8 years and above showed creatinine 
clearance below the lower limits of normal, an 
observation that agrees with the findings of Williams 
(1994). 
Diabetes mellitus is one of the major causes of renal 
morbidity and mortality and diabetic nephropathy is a 
prominent feature in chronic renal failure (Ortega et 
al.2005). Diabetic nephropathy is one of the kidney 
diseases that occur as a result of diabetes mellitus. 
Measurement of the serum urea and creatinine is widely 
used to assess renal integrity and function. An increase 
in urea level is seen when there is damage to the kidney 
or when the kidney is not functioning properly. It has 
been reported that increment in blood urea level in 
confirmed diabetics results from renal damage caused 
by increased blood sugar in the diabetics (Shrestha et 
al., 2008). It has also been reported that increase serum 
urea and creatinine in diabetic rats indicates progressive 
renal damage (Anjaneyulu et al., 2004). Plasma urea 
and creatinine are established markers of glomerular 
filtration rate (GFR) though plasma creatinine is a more 
sensitive index of kidney function compared to plasma 
urea because it fulfills most of the requirements for a 
perfect filtration marker (Perrone et al., 1992). Our 
finding suggests salient progressive degeneration of the 
kidney function and integrity in the diabetic females as 
revealed by the values of the serum creatinine 
measured. Remarkable increase in the upper limit of the 
range of the serum creatinine level was also observed in 
the female diabetics (61.14-117.17 µmol/L). Secondly, 
commencement of progressive loss of renal function in 
the diabetic patients in this study could be predicted by 
the findings of decrease in the lower limit of the 
creatinine clearance values in both the male and female 
type 2 diabetes mellitus patients.  The range of the 
estimated creatinine clearance for the diabetic male and 






findings further strengthened the assertion by Perrone et 
al. (1992) that plasma creatinine is a more sensitive 
index of kidney function when compared with plasma 
urea.  
 
The impact of average years of diabetes (duration of 
exposure to diabetes mellitus) cannot be 
overemphasized. Walaa (2005), has reported that after 
many years of diabetes, the delicate filtering system in 
the kidney becomes destroyed, initially becoming leaky 
to larger blood proteins such as albumin which are then 
lost in the urine. At this stage, the glomerular filtration 
rate begins to reduce tremendously. The present study 
shows that the average age of duration of diabetes 
mellitus with decrease in creatinine clearance is 8 years 
and above in both the male and female diabetics. This 
observation is lower than that obtained by Rehman and 
Hamayun (2004) who reported a duration of diabetes in 
insulin dependent diabetes mellitus (IDDM) 
nephropathy of 13.19 ± 0.22 years.  However, only 
non- insulin dependent diabetic mellitus patients were 
considered in this study.  The reasons for this 
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observation may range from poor diabetic control, 
complications and effect of hypertension in the diabetic 
process, poor dietary habits as a result of the socio-
economic status of the subjects and the fact that most of 
the subjects might have had undiagnosed diabetes for a 
period longer than when diabetes was actually 
diagnosed in them.  
 
Conclusion: This study showed that 51.51% (19.39% 
males and 32.12% females) of the diabetic patients 
were hypertensive and that 30.59% (8.24% males and 
22.35% females) with an average age of duration of 
diabetes 8 years and above show creatinine clearance 
below the lower limits of normal, an observation which 
is an indication of commencement of progressive loss 
of renal function in the diabetic patients who 
participated in the study. In order to monitor the impact 
of type 2 diabetes mellitus and hypertension on the 
integrity of the kidney in diabetics, there is a need to 
include the measurement of creatinine clearance among 
the routine biochemical tests used in the assessment of 
renal function especially in type 2 diabetes mellitus 
patients. The use of Cockroft-Gault equation in the 
estimation of creatinine clearance which clearly 
overcomes the drawbacks often associated with 
creatinine clearance measurement involving collection 
of urine specimens from patients is recommended. This 
is critical in the care of the diabetic patients since 
poorly managed diabetes mellitus could result in the 
development cardiovascular disease, a condition that is 
often complicated and even compromised when 
hypertension has developed in the diabetes mellitus 
patients.   
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